LAPSE:2024.0025
Published Article
LAPSE:2024.0025
Study of the Effect of Eudragit RSPO on the Photostability of Venlafaxine in a Physical Mixture and in a Melt Form
Anna Maślanka, Marek Szlósarczyk, Przemysław Talik, Joanna Szafraniec-Szczęsny, Krzysztof Woyna-Orlewicz, Paweł Żmudzki, Urszula Hubicka
January 5, 2024
The effect of Eudragit RSPO on the photostability of venlafaxine in a physical mixture and as a melt was studied. A validated ultra-high-performance liquid chromatography mass spectrometry method was used to determine the content of venlafaxine alongside degradation products. The most likely structures of the degradation products were determined by mass spectrometry. The samples were evaluated before and after exposure to ultraviolet A by differential scanning calorimetry and scanning electron microscopy. The kinetic parameters of the decomposition of venlafaxine in the physical mixture and melt form were calculated and comparable to those of venlafaxine as an active pharmaceutical ingredient. The results indicate that the process of venlafaxine decomposition is more than three times slower in the venlafaxine−eudragit melt than in its physical mixture with eudragit and its pure form. The strong photoprotective nature of the tested polymer against venlafaxine in the melt form was also confirmed by differential scanning calorimetry and scanning electron microscopy.
Keywords
DSC, eudragit, excipients, kinetic studies, photodegradation, photostability, solid dosage, UHPLC/MS/MS, venlafaxine
Subject
Suggested Citation
Maślanka A, Szlósarczyk M, Talik P, Szafraniec-Szczęsny J, Woyna-Orlewicz K, Żmudzki P, Hubicka U. Study of the Effect of Eudragit RSPO on the Photostability of Venlafaxine in a Physical Mixture and in a Melt Form. (2024). LAPSE:2024.0025
Author Affiliations
Maślanka A: Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland [ORCID]
Szlósarczyk M: Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland [ORCID]
Talik P: Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland [ORCID]
Szafraniec-Szczęsny J: CHDE Polska S.A., Biesiadna 7, 35-304 Rzeszów, Poland
Woyna-Orlewicz K: Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland
Żmudzki P: Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland [ORCID]
Hubicka U: Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland [ORCID]
Journal Name
Processes
Volume
11
Issue
8
First Page
2479
Year
2023
Publication Date
2023-08-18
Published Version
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr11082479, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2024.0025
This Record
External Link

doi:10.3390/pr11082479
Publisher Version
Download
Files
[Download 1v1.pdf] (6.7 MB)
Jan 5, 2024
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
46
Version History
[v1] (Original Submission)
Jan 5, 2024
 
Verified by curator on
Jan 5, 2024
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2024.0025
 
Original Submitter
Calvin Tsay
Links to Related Works
Directly Related to This Work
Publisher Version